ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646127 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646127; 2) Community: the network communities that were significantly associated with the response to NSC 646127; 3) Molecule: the relationships between components within communities and NSC 646127; 4) MDR: the compounds that were significantly associated with the NSC 646127.

NSC Compound Enrichment Correlation
NSC 742799 3-amino-N-(4-benzylphenyl)-1H-indazole-1-carboxamide 0.00010016854108277 -0.24243657
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.000108541161925035 -0.17692303
NSC 726432 Null 0.00012706483944704 -0.13471771
NSC 109834 Null 0.000209334878795459 0.019221769
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.000209334878795459 -0.35977888
NSC 132313 Dianhydrogalactitol 0.000216242727122389 -0.0351273
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.000216242727122389 -0.062113382
NSC 129220 O2,2'-Cyclocytidine monoacetate 0.000374267341249421 -0.093807888
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.000374267341249427 0.045745185
NSC 174121 Methotrexate Derivative 0.000432107380838963 -0.026748254
Total:78  Current:1    [First] [Prev] [Next] [Last]